We compared the performance of the Carba NP test and the Rosco Rapid CARB screen kit for detecting carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Both tests are rapid and highly sensitive; however, the Carba NP test showed superior specificity, and several uninterpretable results were observed with the Rapid CARB screen.
after 30, 60, and 120 min of incubation. Any color change observed by the naked eye from red to yellow in a vial (for the CNP test) or in a tube (for the RCS) was considered to be a positive reaction (pink, orange, or yellow). The CNP test results were interpreted according to the guidelines by Nordmann et al. (2) . The RCS results were interpreted according to the manufacturer's instructions (5) . The results of the CNP and RCS tests were considered negative if the respective test vial/tube gave a negative reaction, positive if the test vial/tube gave a positive reaction and the control vial/tube gave a negative reaction (red), and uninterpretable if the control vial/tube gave a positive reaction. All isolates had been verified for the presence of carbapenemase by an inhouse ISO 15189-validated multiplex PCR targeting bla VIM , bla IMP , bla NDM , bla KPC , and bla OXA-48 (6) . The P. aeruginosa strains were additionally tested by two other in-house multiplex PCRs targeting bla GES (7) and bla (8) .
The CNP and RCS test results for carbapenemase-producing and carbapenemase-negative Enterobacteriaceae and P. aeruginosa collection strains are detailed in Tables 1 and 2 . The large majority of the characterized CPE collection strains yielded strong-positive results (orange or yellow) by the CNP (59/66) or RCS (54/66) test. Two OXA-48 CPE and one IMP-13 CPPA gave a weak-positive result (pink) by the CNP test. The CNP test missed two IMP-13 strains, one GES-18 strain, and one OXA-198 CPPA strain that showed a weak-positive result by the RCS. Two OXA-48-producing Enterobacteriaceae strains had uninterpretable results with the RCS. Among the 69 characterized carbapenemase-negative strains, all had negative results with the CNP test. On the other hand, 7 Enterobacteriaceae and 10 P. aeruginosa carbapenemasenegative strains yielded inconclusive (n ϭ 6) or weak false-positive results (n ϭ 11) by the RCS.
During the study period, a total of 356 consecutive Enterobacteriaceae (n ϭ 135) and P. aeruginosa (n ϭ 221) clinical isolates were referred by 66 laboratories throughout Belgium to the reference laboratory for suspected carbapenemase production, and the results of the CNP and RCS tests for all isolates are detailed in Table 3 . Seventy-two of the 135 (53%) Enterobacteriaceae isolates and 55 of the 221 (25%) P. aeruginosa isolates were confirmed to be carbapenemase producers. OXA-48 carbapenemase was the predominant carbapenemase (82% [59/72]) found in Enterobacteriaceae, while VIM-type carbapenemase largely predominated (93% [51/55]) in P. aeruginosa. By the CNP test, all but 3 OXA-48-positive Enterobacteriaceae (two Klebsiella pneumoniae and one Escherichia coli) and 3 OXA-198-producing P. aeruginosa isolates (clustered in a single hospital and most probably corresponding to a single clone) had positive results. None of the false-negative (by either test) carbapenemase-positive isolates showed mucoid colonies (9) . While no uninterpretable results were observed with the CNP test, 9% of the tested isolates (16/135 Enterobacteriaceae and 17/221 P. aeruginosa) gave an uninterpretable result, showing a positive reaction with the RCS negativecontrol disk.
The overall sensitivity, specificity (calculated on all tested strains), and positive and negative predictive values (calculated on consecutive isolates referred to the reference laboratory) for detecting CPE using the CNP test compared to the molecular detection results were 97%, 100%, 100%, and 95%, respectively, for Enterobacteriaceae, and 91%, 100%, 100%, and 96%, respectively, for P. aeruginosa. After excluding the uninterpretable results, the sensitivity, specificity, and positive and negative predictive values using the RCS were 98%, 83%, 81%, and 95%, respectively, for Enterobacteriaceae, and 96%, 54%, 39%, and 97%, respectively, for P. aeruginosa. If only strong color changes (orange or yellow) were considered a positive result using the RCS, the calculated specificity and positive predictive values increased to 99% and 96%, respectively, while maintaining high sensitivity and negative predictive values of 90% and 96%, respectively, for P. aeruginosa. In addition to the false-negative results observed for a small subset of OXA-48 CPE isolates and for GES-type CPPA isolates using the CNP test that were already reported in other studies (3, 9) , we also observed false-negative results using the CNP test with two of the four IMP-13 and all four OXA-198 CPPA isolates tested. Among the total 73 OXA-48 Enterobacteriaceae isolates tested, which represent the main detection challenge in our setting, the numbers of strong-positive, weak-positive, negative, and uninterpretable re- sults were 62, 8, 3, and 0, respectively, by the CNP test, while they were 49, 14, 2, and 8, respectively, by the RCS. Based on our study experience, the RCS was technically easier to perform, as preparation of the reagents was not required as it is for the CNP test. On the other hand, some difficulty in reading the color changes in the RCS, notably due to the turbidity of the undissolved tablets, together with the nonnegligible number of false-positive and uninterpretable results, are the major drawbacks against its routine implementation.
The Carba NP test and Rapid CARB screen are rapid and highly sensitive screening tests used to exclude carbapenemase in Enterobacteriaceae and P. aeruginosa. In an epidemiological setting with a high prevalence of VIM CPPA isolates, the Rapid CARB screen can be used for confirmation of carbapenemase production in P. aeruginosa only if a strong-positive reaction is used as the criterion for a positive result. However, both screening tests should be used with caution in areas with higher prevalence of OXA-48 CPE and should be evaluated in other epidemiological settings in which carbapenemases with lower hydrolytic activity of carbapenems may be found (e.g., IMP, GES, and OXA-198). The Carba NP test performed better than the Rapid CARB screen, owing to its superior specificity and the large number of uninterpretable results observed with the Rapid CARB screen.
